Sionna Therapeutics

failure crash no fail rocket cancelled end
Biotech

Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex

Sionna said it plans to “take actions to preserve capital while evaluating next steps.”
Nick Paul Taylor Aug 10, 2026 9:38am
Photo of Wall Street street sign with american flags in the background

Sionna goes public in $135M IPO, Aardvark plots $103M listing

Feb 7, 2025 4:40am
IPO initial public offering

Sionna eyes up $156M IPO to fund cystic fibrosis trials

Feb 3, 2025 9:59am
IPO initial public offering Wall Street

Odyssey, Sionna join band of biotechs braving the IPO waters

Jan 21, 2025 5:27am
spectrum up arrow grow direction

TPG tops up funds to $580M for investments across life sciences

Aug 6, 2024 11:45am
x ray cystic fibrosis

Sionna salvages AbbVie assets for assault on cystic fibrosis

Jul 16, 2024 10:00am